Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma › Research Explorer

DOI

https://doi.org/10.1186/s12920-019-0484-9
Final published version

Elena N. Voropaeva
Tatyana I. Pospelova
Mikhail I. Voevoda
Vladimir N. Maksimov
Yuriy L. Orlov
Olga B. Seregina

Original language	English
Article number	35
Pages (from-to)	35
Number of pages	10
Journal	BMC Medical Genomics
Volume	12
Issue number	Suppl 2
DOIs	https://doi.org/10.1186/s12920-019-0484-9
Publication status	Published - 13 Mar 2019

Research areas

Allelic imbalance, Diffuse large B-cell lymphoma, Intron mutations, Methylation, Sequencing, TP53 gene, TRANSCRIPTIONAL ACTIVITY, PROGNOSTIC IMPACT, METHYLATION, TUMOR-SUPPRESSOR GENE, HETEROZYGOSITY, P53 MUTATIONS, MUTANTS, PROMOTER, EXPRESSION, CARCINOMA

OECD FOS+WOS

ID: 18858966